BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 34508245)

  • 1. How COVID is derailing the fight against HIV, TB and malaria.
    Roberts L
    Nature; 2021 Sep; 597(7876):314. PubMed ID: 34508245
    [No Abstract]   [Full Text] [Related]  

  • 2. Disrupted care in Papua New Guinea: the harms of COVID-19.
    McCall C
    Lancet; 2022 Jan; 399(10321):226-227. PubMed ID: 35033215
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and syndemic challenges in 'Battling the Big Three': HIV, TB and malaria.
    Velavan TP; Meyer CG; Esen M; Kremsner PG; Ntoumi F;
    Int J Infect Dis; 2021 May; 106():29-32. PubMed ID: 33781904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa.
    Coker M; Folayan MO; Michelow IC; Oladokun RE; Torbunde N; Sam-Agudu NA
    Pediatr Res; 2021 Apr; 89(5):1078-1086. PubMed ID: 32971527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of outcomes associated to types of HIV coinfection with TB and malaria in a setting where the three pandemics overlap.
    Tshikuka Mulumba JG; Atua Matindii B; Kilauzi AL; Mengema B; Mafuta J; Eloko Eya Matangelo G; Mukongo Bulaïmu-Lukeba A; Jerry IL
    J Community Health; 2012 Dec; 37(6):1234-8. PubMed ID: 22477668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintaining robust HIV and tuberculosis services in the COVID-19 era: A public health dilemma in Zimbabwe.
    Mukwenha S; Dzinamarira T; Mugurungi O; Musuka G
    Int J Infect Dis; 2020 Nov; 100():394-395. PubMed ID: 32979586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to stop COVID-19 fuelling a resurgence of AIDS, malaria and tuberculosis.
    Nature; 2020 Aug; 584(7820):169. PubMed ID: 32788740
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study.
    Hogan AB; Jewell BL; Sherrard-Smith E; Vesga JF; Watson OJ; Whittaker C; Hamlet A; Smith JA; Winskill P; Verity R; Baguelin M; Lees JA; Whittles LK; Ainslie KEC; Bhatt S; Boonyasiri A; Brazeau NF; Cattarino L; Cooper LV; Coupland H; Cuomo-Dannenburg G; Dighe A; Djaafara BA; Donnelly CA; Eaton JW; van Elsland SL; FitzJohn RG; Fu H; Gaythorpe KAM; Green W; Haw DJ; Hayes S; Hinsley W; Imai N; Laydon DJ; Mangal TD; Mellan TA; Mishra S; Nedjati-Gilani G; Parag KV; Thompson HA; Unwin HJT; Vollmer MAC; Walters CE; Wang H; Wang Y; Xi X; Ferguson NM; Okell LC; Churcher TS; Arinaminpathy N; Ghani AC; Walker PGT; Hallett TB
    Lancet Glob Health; 2020 Sep; 8(9):e1132-e1141. PubMed ID: 32673577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laggard rich countries risk slowing the fight against AIDS, malaria and TB.
    Nature; 2022 Oct; 610(7930):8. PubMed ID: 36198783
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuberculosis, HIV/AIDS and Malaria Health Services in sub-Saharan Africa - A Situation Analysis of the Disruptions and Impact of the COVID-19 Pandemic.
    Chanda-Kapata P; Ntoumi F; Kapata N; Lungu P; Mucheleng'anga LA; Chakaya J; Tembo J; Himwaze C; Ansumana R; Asogun D; Mfinanga S; Nyasulu P; Mwaba P; Yeboah-Manu D; Zumla A; Nachega JB
    Int J Infect Dis; 2022 Nov; 124 Suppl 1():S41-S46. PubMed ID: 35341998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part II: Determinants operating at environmental and institutional level.
    Bates I; Fenton C; Gruber J; Lalloo D; Lara AM; Squire SB; Theobald S; Thomson R; Tolhurst R
    Lancet Infect Dis; 2004 Jun; 4(6):368-75. PubMed ID: 15172345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against the big three killers: an illusion?
    Raoult D; Parola P
    Clin Microbiol Infect; 2019 Jun; 25(6):654-655. PubMed ID: 30898723
    [No Abstract]   [Full Text] [Related]  

  • 13. African HIV/AIDS specialists recommend how US$1.5 billion Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria should be spent.
    Cent Afr J Med; 2002; 48(3-4):50. PubMed ID: 12971158
    [No Abstract]   [Full Text] [Related]  

  • 14. From the big three to the big four.
    Chen DS; Locarnini S; Wallace J
    Lancet Infect Dis; 2015 Jun; 15(6):626-7. PubMed ID: 26008824
    [No Abstract]   [Full Text] [Related]  

  • 15. How TB and COVID-19 compare: an opportunity to integrate both control programmes.
    Echeverría G; Espinoza W; de Waard JH
    Int J Tuberc Lung Dis; 2020 Sep; 24(9):971-974. PubMed ID: 33156768
    [No Abstract]   [Full Text] [Related]  

  • 16. [Global challenges with HIV, malaria and tuberculosis].
    Ekström AM; Färnert A; Thorson A; Alfvén T
    Lakartidningen; 2013 Jan 9-15; 110(1-2):33-6. PubMed ID: 23373183
    [No Abstract]   [Full Text] [Related]  

  • 17. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and TB control in immigrant communities.
    Wilson FA; Miller TL; Stimpson JP
    Int J Tuberc Lung Dis; 2020 Sep; 24(9):975-977. PubMed ID: 33156769
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis management in India during COVID-19 crisis.
    Awasthi AK; Singh PK
    J Public Health Policy; 2021 Mar; 42(1):185-189. PubMed ID: 33235251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging consensus in HIV/AIDS, malaria, tuberculosis, and access to essential medicines.
    Ruxin J; Paluzzi JE; Wilson PA; Tozan Yi; Kruk M; Teklehaimanot A
    Lancet; 2005 Feb 12-18; 365(9459):618-21. PubMed ID: 15708108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.